Chugai Pharmaceutical Co Stock Price Prediction
| CHGCY Stock | USD 20.69 0.17 0.83% |
Oversold Vs Overbought
44
Oversold | Overbought |
Using Chugai Pharmaceutical hype-based prediction, you can estimate the value of Chugai Pharmaceutical Co from the perspective of Chugai Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Chugai Pharmaceutical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Chugai because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Chugai Pharmaceutical after-hype prediction price | USD 20.69 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Chugai |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Chugai Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Chugai Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Chugai Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Chugai Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Chugai Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Chugai Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Chugai Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Chugai Pharmaceutical's historical news coverage. Chugai Pharmaceutical's after-hype downside and upside margins for the prediction period are 18.09 and 23.29, respectively. We have considered Chugai Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Chugai Pharmaceutical is not too volatile at this time. Analysis and calculation of next after-hype price of Chugai Pharmaceutical is based on 3 months time horizon.
Chugai Pharmaceutical Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Chugai Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chugai Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Chugai Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 2.60 | 0.00 | 0.23 | 0 Events / Month | 7 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
20.69 | 20.69 | 0.00 |
|
Chugai Pharmaceutical Hype Timeline
Chugai Pharmaceutical is currently traded for 20.69. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.23. Chugai is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.23%. %. The volatility of related hype on Chugai Pharmaceutical is about 265.31%, with the expected price after the next announcement by competition of 20.92. The book value of the company was currently reported as 432.94. The company last dividend was issued on the 29th of June 2022. Chugai Pharmaceutical had 12:1 split on the 6th of July 2020. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out Chugai Pharmaceutical Basic Forecasting Models to cross-verify your projections.Chugai Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Chugai Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Chugai Pharmaceutical's future price movements. Getting to know how Chugai Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Chugai Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| OPHLY | Ono Pharmaceutical Co | 0.00 | 0 per month | 0.00 | (0.30) | 2.41 | (2.55) | 10.36 | |
| GLAXF | GSK plc | 0.00 | 0 per month | 0.00 | (0.12) | 5.20 | (5.86) | 17.25 | |
| GRFS | Grifols SA ADR | (0.11) | 8 per month | 2.17 | 0.07 | 6.68 | (4.39) | 23.63 | |
| PFE | Pfizer Inc | (0.04) | 8 per month | 0.00 | (0.21) | 2.17 | (2.45) | 8.17 | |
| IONQ | IONQ Inc | (0.87) | 10 per month | 4.15 | 0.30 | 16.30 | (6.53) | 47.83 | |
| RCAT | Red Cat Holdings | 0.34 | 9 per month | 4.93 | 0.17 | 13.75 | (8.36) | 29.03 | |
| ENB | Enbridge | 0.61 | 13 per month | 0.41 | 0.09 | 1.41 | (1.04) | 3.55 | |
| GOOG | Alphabet Inc Class C | (2.14) | 7 per month | 1.57 | (0.01) | 2.21 | (1.96) | 5.99 | |
| GNPX | Genprex | 0.01 | 6 per month | 8.89 | 0.11 | 38.38 | (19.25) | 294.48 | |
| NFLX | Netflix | 12.00 | 7 per month | 1.16 | 0.14 | 2.80 | (2.33) | 13.04 |
Chugai Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Chugai price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Chugai using various technical indicators. When you analyze Chugai charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Chugai Pharmaceutical Predictive Indicators
The successful prediction of Chugai Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Chugai Pharmaceutical Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Chugai Pharmaceutical based on analysis of Chugai Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Chugai Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chugai Pharmaceutical's related companies.
Story Coverage note for Chugai Pharmaceutical
The number of cover stories for Chugai Pharmaceutical depends on current market conditions and Chugai Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Chugai Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Chugai Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Chugai Pharmaceutical Short Properties
Chugai Pharmaceutical's future price predictability will typically decrease when Chugai Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Chugai Pharmaceutical Co often depends not only on the future outlook of the potential Chugai Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chugai Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.3 B | |
| Cash And Short Term Investments | 472 B |
Additional Tools for Chugai Pink Sheet Analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.